On March 21, 2016, Echo Therapeutics, Inc. issued a promissory note to Platinum Partners Value Arbitrage Fund L.P. (Lender") in the aggregate principal amount of $150,000 in respect of a bridge loan made by such party. The promissory note, which bears interest at the prime rate, may, at Lender's option, be exchanged for securities issued in a subsequent financing by the Company, including the second tranche financing described in the filing with the SEC on February 3, 2016.
Echo Therapeutics, Inc.
Equities
ECTE
US27876L2060
Advanced Medical Equipment & Technology
1st Jan change | Capi. | |
---|---|---|
+0.91% | 204B | |
+3.74% | 178B | |
+28.89% | 154B | |
+31.66% | 112B | |
+1.37% | 64.16B | |
+19.45% | 54.88B | |
-2.27% | 46.69B | |
-9.28% | 36.8B | |
-0.10% | 35.26B |